The SaltFacial: A Novel Combination Therapy in Aesthetic Medicine and Reconstructive Surgery: Outperforms Old Standards for Aging Skin, Acne, Infection, & Wound Healing

The SaltFacial® Skin Renewal Therapy Greatly Outperformed Hydrating Facials, Microdermabrasion, and Topical Antibiotic Treatments

NEWS PROVIDED BY SaltMED™
May 23, 2021 10:23 ET

Cardiff CA, May 22, 2021/PRNewswire/– A recently published “Research Article” in the Journal of Clinical and Cosmetic Dermatology by Gregory Chernoff, M.D., F.R.C.S.(C) of Chernoff Plastic Surgery, Indianapolis, IN highlights the overwhelming results of a multi-modality platform that has gained popularity and rapid traction in the medical-aesthetics market – The SaltFacial®.

The purpose of the study was to examine the safety and potential efficacy of this new 3 technology platform (SaltFacial) as an effective single session treatment for anti-aging, acne, infection, and wound healing – as compared to microdermabrasion, hydrating facials, or topical therapy alone. The study examined 20 aging skin patients, 16 acne patients, 16 patients with post-surgical infection, and 40 patients with post-surgical edema, bruising, and actively healing wounds over 4-week follow up visits for 12 weeks.

Some impressive results from The SaltFacial study include:

• In the Aging Skin Population – The SaltFacial proved more efficacious than microdermabrasion or hydrating facials in wrinkle reduction, pore size reduction, improved skin evenness, reduced oiliness, reduced pigmentation, and a reduction of unwanted blemishes. Patients had a much higher satisfaction rate with The SaltFacial. 80% reported being extremely satisfied, 10% were very satisfied and 10% were satisfied.
• In the Acne Patient Population – acne-induced inflammation and erythema were reduced by 72.5% in The SaltFacial patients compared to 36.8% in patients treated with oral and topical antibiotics alone.
• In the Post-Surgical Infection Patients – The SaltFacial’s high-intensity LED light therapy reduced the mean days of recovery by 5.6 days – with full resolution of infection, inflammation, erythema, and pain at 5.8 days compared to the 11.4 days in patients treated with traditional culture-specific antibiotic therapy alone.

The results of this study show quantifiable evidence in The SaltFacial’s ability to provide unparalleled results for treating a variety of aesthetic, medical, dermatologic, and surgical conditions.

About SaltMED: SaltMED, incorporated in 2005, the company is committed to creating innovative medical aesthetic solutions for patients and practitioners worldwide. SaltMED is the patent holder of The SaltFacial, a registered trademark of SaltMED.

Learn more about The SaltFacial here.

Contact: Jessica Relyea
SaltMED™
(760) 814-0010
info@thesaltfacial.com